Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6476
PUT
Adeia
ADEA
$2.55B
| $103K | ﹤0.01% |
10,206
-29,484
| -74% | -$302K |
|
6477
CALL
Avanos Medical
AVNS
| $103K | ﹤0.01% |
2,544
-1,596
| -39% | -$71.6K |
|
|
CARM
6478
DELISTED
Carisma Therapeutics
CARM
| $103K | ﹤0.01% |
1,823
+1,047
| +135% | +$148K |
|
|
BGMS
6479
Bio Green Med Solution Inc
BGMS
$4.86M
| – | – |
0
| – | – |
|
6480
PUT
Newell Brands
NWL
$2.21B
| $103K | ﹤0.01% |
2,500
-6,100
| -71% | -$244K |
|
6481
PUT
SEI Investments
SEIC
$12.3B
| $103K | ﹤0.01% |
+2,100
| New | +$98.8K |
|
6482
CALL
Semtech
SMTC
$9.65B
| $103K | ﹤0.01% |
5,200
-6,000
| -54% | -$140K |
|
6483
Stereotaxis
STXS
$133M
| $103K | ﹤0.01% |
89,629
+5,785
| +7% | +$8.43K |
|
|
TPH
6484
CALL
DELISTED
Tri Pointe Homes
TPH
| $103K | ﹤0.01% |
6,700
-12,900
| -66% | -$192K |
|
6485
PUT
Veeco
VECO
$2.62B
| $103K | ﹤0.01% |
3,600
-5,800
| -62% | -$178K |
|
|
RLOG
6486
DELISTED
Rand Logistics, Inc.
RLOG
| $103K | ﹤0.01% |
31,672
+2,776
| +10% | +$9.37K |
|
6487
CALL
Ziff Davis
ZD
$2B
| $102K | ﹤0.01% |
1,725
+230
| +15% | +$13.6K |
|
|
CVA
6488
CALL
DELISTED
Covanta Holding Corporation
CVA
| $102K | ﹤0.01% |
4,800
+4,700
| +4,700% | +$103K |
|
|
ITG
6489
PUT
DELISTED
Investment Technology Group Inc
ITG
| $102K | ﹤0.01% |
4,100
-4,500
| -52% | -$128K |
|
|
CBR
6490
DELISTED
CIBER Inc.
CBR
| $102K | ﹤0.01% |
29,546
-2,085
| -7% | -$7.59K |
|
6491
PUT
Hovnanian Enterprises
HOV
$779M
| $101K | ﹤0.01% |
1,512
-676
| -31% | -$53.2K |
|
|
BLPH
6492
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $101K | ﹤0.01% |
846
-307
| -27% | -$41.7K |
|
|
TEP
6493
PUT
DELISTED
Tallgrass Energy Partners, LP
TEP
| $101K | ﹤0.01% |
2,100
+1,100
| +110% | +$54.4K |
|
|
GDF
6494
DELISTED
WESTERN ASSET GLB PARTNERS INCM FUND INC. COM
GDF
| $101K | ﹤0.01% |
+11,020
| New | +$105K |
|
|
GDP
6495
CALL
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $101K | ﹤0.01% |
54,500
+4,000
| +8% | +$12.5K |
|
|
ZGNX
6496
DELISTED
Zogenix, Inc.
ZGNX
| $101K | ﹤0.01% |
7,545
-769
| -9% | -$9.43K |
|
6497
CALL
eHealth
EHTH
$41.9M
| $100K | ﹤0.01% |
7,900
+3,000
| +61% | +$36.3K |
|
6498
CALL
FMC
FMC
$1.25B
| $100K | ﹤0.01% |
2,191
-8,301
| -79% | -$412K |
|
6499
CALL
ITT
ITT
$17.1B
| $100K | ﹤0.01% |
2,400
-3,000
| -56% | -$125K |
|
6500
CALL
National Fuel Gas
NFG
$7.69B
| $100K | ﹤0.01% |
1,700
+1,200
| +240% | +$75.8K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.